Neuroleptic Malignant Syndrome in a Patient with Corticobasal Degeneration
Parkinson’s disease is a principal underlying disease of neuroleptic malignant syndrome (NMS) occurring in parkinsonian disorders, but NMS may occur in patients with progressive supranuclear palsy and multiple system atrophy. We report first patient with corticobasal degeneration (CBD) who developed...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Korean Movement Disorder Society
2011-10-01
|
| Series: | Journal of Movement Disorders |
| Subjects: | |
| Online Access: | http://e-jmd.org/upload/jmd-4-2-73-5.pdf |
| _version_ | 1797716044102500352 |
|---|---|
| author | Myung Jun Lee Chul Hyoung Lyoo Myung Sik Lee |
| author_facet | Myung Jun Lee Chul Hyoung Lyoo Myung Sik Lee |
| author_sort | Myung Jun Lee |
| collection | DOAJ |
| description | Parkinson’s disease is a principal underlying disease of neuroleptic malignant syndrome (NMS) occurring in parkinsonian disorders, but NMS may occur in patients with progressive supranuclear palsy and multiple system atrophy. We report first patient with corticobasal degeneration (CBD) who developed NMS after abrupt reduction of antiparkinsonian medication and concurrent infection. It should be kept in mind that the prevention of infectious illness, which is common complication in parkinson-plus syndrome, is important, and dose reduction or withdrawal of anti-parkinsonian medications should be carefully performed even in the patients with CBD who are expected to be unresponsive to levodopa treatment. |
| first_indexed | 2024-03-12T08:15:42Z |
| format | Article |
| id | doaj.art-4dcd268b1e414f249c9df74cd99822f8 |
| institution | Directory Open Access Journal |
| issn | 2005-940X 2093-4939 |
| language | English |
| last_indexed | 2024-03-12T08:15:42Z |
| publishDate | 2011-10-01 |
| publisher | Korean Movement Disorder Society |
| record_format | Article |
| series | Journal of Movement Disorders |
| spelling | doaj.art-4dcd268b1e414f249c9df74cd99822f82023-09-02T18:53:32ZengKorean Movement Disorder SocietyJournal of Movement Disorders2005-940X2093-49392011-10-0142737410.14802/jmd.1101527Neuroleptic Malignant Syndrome in a Patient with Corticobasal DegenerationMyung Jun LeeChul Hyoung LyooMyung Sik LeeParkinson’s disease is a principal underlying disease of neuroleptic malignant syndrome (NMS) occurring in parkinsonian disorders, but NMS may occur in patients with progressive supranuclear palsy and multiple system atrophy. We report first patient with corticobasal degeneration (CBD) who developed NMS after abrupt reduction of antiparkinsonian medication and concurrent infection. It should be kept in mind that the prevention of infectious illness, which is common complication in parkinson-plus syndrome, is important, and dose reduction or withdrawal of anti-parkinsonian medications should be carefully performed even in the patients with CBD who are expected to be unresponsive to levodopa treatment.http://e-jmd.org/upload/jmd-4-2-73-5.pdfCorticobasal degenerationNeuroleptic malignant syndrome |
| spellingShingle | Myung Jun Lee Chul Hyoung Lyoo Myung Sik Lee Neuroleptic Malignant Syndrome in a Patient with Corticobasal Degeneration Journal of Movement Disorders Corticobasal degeneration Neuroleptic malignant syndrome |
| title | Neuroleptic Malignant Syndrome in a Patient with Corticobasal Degeneration |
| title_full | Neuroleptic Malignant Syndrome in a Patient with Corticobasal Degeneration |
| title_fullStr | Neuroleptic Malignant Syndrome in a Patient with Corticobasal Degeneration |
| title_full_unstemmed | Neuroleptic Malignant Syndrome in a Patient with Corticobasal Degeneration |
| title_short | Neuroleptic Malignant Syndrome in a Patient with Corticobasal Degeneration |
| title_sort | neuroleptic malignant syndrome in a patient with corticobasal degeneration |
| topic | Corticobasal degeneration Neuroleptic malignant syndrome |
| url | http://e-jmd.org/upload/jmd-4-2-73-5.pdf |
| work_keys_str_mv | AT myungjunlee neurolepticmalignantsyndromeinapatientwithcorticobasaldegeneration AT chulhyounglyoo neurolepticmalignantsyndromeinapatientwithcorticobasaldegeneration AT myungsiklee neurolepticmalignantsyndromeinapatientwithcorticobasaldegeneration |